From data to policy: two-dose meningococcal vaccine series are highly immunogenic
Crossref DOI link: https://doi.org/10.1038/s41390-025-03940-2
Published Online: 2025-02-17
Published Print: 2025-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Blatt, Adam Z.
Smith, Michael J.
Text and Data Mining valid from 2025-02-17
Version of Record valid from 2025-02-17
Article History
Received: 18 January 2025
Accepted: 26 January 2025
First Online: 17 February 2025
Competing interests
: M.J.S. has received funding paid to the institution from Pfizer for vaccine clinical trials.